{"id":{"repo_id":"whiterose","oai_identifier":"oai:etheses.whiterose.ac.uk:28167"},"canonical_url":"https://search.ndltd.org/etd/whiterose/oai:etheses.whiterose.ac.uk:28167","repository":{"repo_id":"whiterose","name":"White Rose University Consortium","base_url":"https://etheses.whiterose.ac.uk/cgi/oai2"},"display":{"title":"Investigating the mutation spectrum for Familial Exudative Vitreoretinopathy (FEVR)","abstract":"Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal eye disease, which can lead to vision loss or total blindness. It is characterized by abnormal development of blood vessels in the retina, which may trigger neovascularization leading to retinal folds and detachment. FEVR is genetically heterogeneous with eleven genes reported to date (NDP, FZD4, LRP5, TSPAN12, CTNNB1, KIF11, ZNF408, ATOH7, RCBTB1, JAG1 and ILK) and an ever-increasing number of variants being reported in these. This project focused on generating a mutation database and spectrum for FEVR. Variant information was gathered either from unpublished data from the Toomes’ lab or from peer-reviewed journal articles. All of the mutations were annotated so that they complied with the latest Human Genome Variation Society nomenclature and were uploaded onto the Leiden Open Variation Database. Pathogenicity classifications of variants were reassessed using the latest pathogenic prediction tools and frequency data and were classified according to the American College of Medical Genetics (ACMG) guidelines. In addition, missense mutant protein structures were predicted using Modeller9.24 software and compared with the correspondent wildtype protein model using UCSF chimera to attempt to highlight differences to aid in variant classification.","abstract_html":"Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal eye disease, which can lead to vision loss or total blindness. It is characterized by abnormal development of blood vessels in the retina, which may trigger neovascularization leading to retinal folds and detachment. FEVR is genetically heterogeneous with eleven genes reported to date (NDP, FZD4, LRP5, TSPAN12, CTNNB1, KIF11, ZNF408, ATOH7, RCBTB1, JAG1 and ILK) and an ever-increasing number of variants being reported in these. This project focused on generating a mutation database and spectrum for FEVR. Variant information was gathered either from unpublished data from the Toomes’ lab or from peer-reviewed journal articles. All of the mutations were annotated so that they complied with the latest Human Genome Variation Society nomenclature and were uploaded onto the Leiden Open Variation Database. Pathogenicity classifications of variants were reassessed using the latest pathogenic prediction tools and frequency data and were classified according to the American College of Medical Genetics (ACMG) guidelines. In addition, missense mutant protein structures were predicted using Modeller9.24 software and compared with the correspondent wildtype protein model using UCSF chimera to attempt to highlight differences to aid in variant classification.","abstract_has_math":false,"creators":["Sun, Dong"],"institution":"University of Leeds","degree_name":"M.Sc by research","degree_level":"masters","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Toomes, Carmel","Inglehearn, Chris","Poulter, James"],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-09","date_published":"2020-09","updated_at":"2026-11-18T22:40:49Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000203490821"],"render_values":[{"text":"0000-0002-0349-0821","href":"https://orcid.org/0000-0002-0349-0821","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://etheses.whiterose.ac.uk/id/eprint/28167/1/Sun_D_Medicine_MRes_2020.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.whiterose.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.whiterose.ac.uk%3A28167","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Toomes, Carmel","Inglehearn, Chris","Poulter, James"]},{"key":"dc:creator","label":"Author","values":["Sun, Dong"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000203490821"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-09"]},{"key":"dc:date.issued","label":"Date","values":["2020-09"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["School of Medicine (Leeds)"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Leeds"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://etheses.whiterose.ac.uk/id/eprint/28167/"]},{"key":"dc:relation.references","label":"Dc Relation References","values":["[1] Mutations and New Variation: Overview. eLS. [2] ADZHUBEI, I. A., SCHMIDT, S., PESHKIN, L., RAMENSKY, V. E., GERASIMOVA, A., BORK, P., KONDRASHOV, A. S. & SUNYAEV, S. R. 2010. A method and server for predicting damaging missense mutations. Nature methods, 7, 248-249. [3] AVILA-FERNANDEZ, A., PEREZ-CARRO, R., CORTON, M., LOPEZ-MOLINA, M. I., CAMPELLO, L., GARANTO, A., FERNANDEZ-SANCHEZ, L., DUIJKERS, L., LOPEZ- MARTINEZ, M. A. & RIVEIRO-ALVAREZ, R. 2015. Whole-exome sequencing reveals ZNF408 as a new gene associated with autosomal recessive retinitis pigmentosa with vitreal alterations. Human molecular genetics, 24, 4037-4048. [4] BANG, I., KIM, H. R., BEAVEN, A. H., KIM, J., KO, S.-B., LEE, G. R., KAN, W., LEE, H., IM, W. & SEOK, C. 2018. Biophysical and functional characterization of Norrin signaling through Frizzled4. Proceedings of the National Academy of Sciences, 115, 8787-8792. [5] BARRESI, M. J. F., BURTON, S., DIPIETRANTONIO, K., AMSTERDAM, A., HOPKINS, N. & KARLSTROM, R. O. 2010. Essential genes for astroglial development and axon pathfinding during zebrafish embryogenesis. Developmental dynamics : an official publication of the American Association of Anatomists, 239, 2603-2618. [6] BERGER, W., VAN DE POL, D., BÄCHNER, D., OERLEMANS, F., WINKENS, H., HAMEISTER, H., WIERINGA, B., HENDRIKS, W. & ROPERS, H. H. 1996. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Hum Mol Genet, 5, 51-9. [7] BRANDIS, G. & HUGHES, D. 2016. The Selective Advantage of Synonymous Codon Usage Bias in Salmonella. PLOS Genetics, 12, e1005926. [8] BROWN, N. L., PATEL, S., BRZEZINSKI, J. & GLASER, T. 2001. <em>Math5</em> is required for retinal ganglion cell and optic nerve formation. Development, 128, 2497-2508. [9] BUCHER, F., FRIEDLANDER, M. & YEA, K. 2018. Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy. Oncotarget, 9, 12538. [10] CHANG, T.-H., HSIEH, F.-L., ZEBISCH, M., HARLOS, K., ELEGHEERT, J. & JONES, E. Y. 2015. Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan. Elife, 4, e06554. [11] CHARETTE, J. R., EARP, S. E., BELL, B. A., ACKERT-BICKNELL, C. L., GODFREY, D. A., RAO, S., ANAND-APTE, B., NISHINA, P. M. & PEACHEY, N. S. 2017. A mutagenesis-derived Lrp5 mouse mutant with abnormal retinal vasculature and low bone mineral density. Molecular Vision, 23, 140. [12] CHEN, Z., BATTINELLI, E., FIELDER, A., BUNDEY, S., SIMS, K., BREAKEFIELD, X. & CRAIG, I. 1993a. A mutation in the norrie disease gene (ndp) associated with x–linked familial exudative vitreoretinopathy. Nature genetics, 5, 180. [13] CHEN, Z. Y., BATTINELLI, E. M., FIELDER, A., BUNDEY, S., SIMS, K., BREAKEFIELD, X. O. & CRAIG, I. W. 1993b. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet, 5, 180-3. [14] CHENG, J., RANDALL, A. & BALDI, P. 2006. Prediction of protein stability changes for single- site mutations using support vector machines. Proteins, 62, 1125-32. 58 [15] CHENG, J., RANDALL, A. Z., SWEREDOSKI, M. J. & BALDI, P. 2005. SCRATCH: a protein structure and structural feature prediction server. Nucleic acids research, 33, W72-W76. [16] CHOI, Y. & CHAN, A. P. 2015. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 31, 2745-2747. [17] CLEVERS, H. 2009. Eyeing up new Wnt pathway players. Cell, 139, 227-229. [18] COLLIN, R. W., NIKOPOULOS, K., DONA, M., GILISSEN, C., HOISCHEN, A., BOONSTRA, F. N., POULTER, J. A., KONDO, H., BERGER, W. & TOOMES, C. 2013. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature. Proceedings of the National Academy of Sciences, 110, 9856-9861. [19] COLLINS, J. S. & SCHWARTZ, C. E. 2002. Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet, 71, 1251-2. [20] COLOVOS, C. & YEATES, T. O. 1993. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci, 2, 1511-9. [21] COPPIETERS, F., ASCARI, G., DANNHAUSEN, K., NIKOPOULOS, K., PEELMAN, F., KARLSTETTER, M., XU, M., BRACHET, C., MEUNIER, I. & TSILIMBARIS, M. K. 2016. Isolated and syndromic retinal dystrophy caused by biallelic mutations in RCBTB1, a gene implicated in ubiquitination. The American Journal of Human Genetics, 99, 470-480. [22] CRISWICK, V. & SCHEPENS, C. 1969. Familial exudative vitreoretinopathy. American journal of ophthalmology, 68, 578-594. [23] DE LIGT, J., WILLEMSEN, M. H., VAN BON, B. W., KLEEFSTRA, T., YNTEMA, H. G., KROES, T., VULTO-VAN SILFHOUT, A. T., KOOLEN, D. A., DE VRIES, P. & GILISSEN, C. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 367, 1921-1929. [24] DEN DUNNEN, J. T., DALGLEISH, R., MAGLOTT, D. R., HART, R. K., GREENBLATT, M. S., MCGOWAN-JORDAN, J., ROUX, A.-F., SMITH, T., ANTONARAKIS, S. E. & TASCHNER, P. E. M. 2016. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Human Mutation, 37, 564-569. [25] DOWNEY , L., BOTTOMLEY , H., SHERIDAN, E., AHMED, M., GILMOUR, D., INGLEHEARN, C., REDDY, A., AGRAWAL, A., BRADBURY, J. & TOOMES, C. 2006. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. British journal of ophthalmology, 90, 1163-1167. [26] DOWNEY , L., KEEN, T., ROBERTS, E., MANSFIELD, D., BAMASHMUS, M. & INGLEHEARN, C. 2001. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. The American Journal of Human Genetics, 68, 778-781. DRENSER, K. A. 2016. Wnt signaling pathway in retinal vascularization. Eye and Brain, 8, 141. [27] DUBRUC, E., PUTOUX, A., LABALME, A., ROUGEOT, C., SANLAVILLE, D. & EDERY, P. 2014. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. American Journal of Medical Genetics Part A, 164, 1571-1575. [28] EISENBERG, D., LÜTHY, R. & BOWIE, J. U. 1997. [20] VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology. Academic Press. [29] EXERTIER, P., JAVERZAT, S., WANG, B., FRANCO, M., HERBERT, J., PLATONOVA, N., WINANDY, M., PUJOL, N., NIVELLES, O., ORMENESE, S., GODARD, V., BECKER, J., 59 BICKNELL, R., PINEAU, R., WILTING, J., BIKFALVI, A. & HAGEDORN, M. 2013. Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5. Oncotarget, 4, 2302- 2316. [30] FISCHETTO, R., PALMIERI, V. V., TRIPALDI, M. E., GAETA, A., MICHELUCCI, A., DELVECCHIO, M., FRANCAVILLA, R. & GIORDANO, P. 2019. Alagille Syndrome: A Novel Mutation in JAG1 Gene. Frontiers in pediatrics, 7, 199-199. [31] GANDHI, J. K., TOLLEFSON, T. T. & TELANDER, D. G. 2014. Falciform macular folds and chromosome 22q11.2: evidence in support of a locus for familial exudative vitreoretinopathy (FEVR). Ophthalmic Genet, 35, 112-6. [32] GHIASVAND, N. M., RUDOLPH, D. D., MASHAYEKHI, M., BRZEZINSKI IV, J. A., GOLDMAN, D. & GLASER, T. 2011. Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease. Nature neuroscience, 14, 578. [33] GILISSEN, C., HOISCHEN, A., BRUNNER, H. G. & VELTMAN, J. A. 2012. Disease gene identification strategies for exome sequencing. Eur J Hum Genet, 20, 490-7. [34] GILMOUR, D. 2015. Familial exudative vitreoretinopathy and related retinopathies. Eye, 29, 1- 14. [35] GILMOUR, D. F., DOWNEY, L. M., SHERIDAN, E., LONG, V., BRADBURY, J., INGLEHEARN, C. F. & TOOMES, C. 2009. Familial exudative vitreoretinopathy and DiGeorge syndrome: a new locus for familial exudative vitreoretinopathy on chromosome 22q11. 2? Ophthalmology, 116, 1522-1524. [36] GONG, Y., SLEE, R. B., FUKAI, N., RAWADI, G., ROMAN-ROMAN, S., REGINATO, A. M., WANG, H., CUNDY, T., GLORIEUX, F. H., LEV, D., ZACHARIN, M., OEXLE, K., MARCELINO, J., SUWAIRI, W., HEEGER, S., SABATAKOS, G., APTE, S., ADKINS, W. N., ALLGROVE, J., ARSLAN-KIRCHNER, M., BATCH, J. A., BEIGHTON, P., BLACK, G. C., BOLES, R. G., BOON, L. M., BORRONE, C., BRUNNER, H. G., CARLE, G. F., DALLAPICCOLA, B., DE PAEPE, A., FLOEGE, B., HALFHIDE, M. L., HALL, B., HENNEKAM, R. C., HIROSE, T., JANS, A., JÜPPNER, H., KIM, C. A., KEPPLER-NOREUIL, K., KOHLSCHUETTER, A., LACOMBE, D., LAMBERT, M., LEMYRE, E., LETTEBOER, T., PELTONEN, L., RAMESAR, R. S., ROMANENGO, M., SOMER, H., STEICHEN-GERSDORF, E., STEINMANN, B., SULLIVAN, B., SUPERTI-FURGA, A., SWOBODA, W., VAN DEN BOOGAARD, M. J., VAN HUL, W., VIKKULA, M., VOTRUBA, M., ZABEL, B., GARCIA, T., BARON, R., OLSEN, B. R. & WARMAN, M. L. 2001. LDL receptor- related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513-23. [37] GOTTARDI, C. J. & PEIFER, M. 2008. Terminal regions of beta-catenin come into view. Structure, 16, 336-8. [38] GOW, J. & OLIVER, G. L. 1971. Familial exudative vitreoretinopathy: an expanded view. Archives of Ophthalmology, 86, 150-155. [39] GRONT, D., KMIECIK, S., BLASZCZYK, M., EKONOMIUK, D. & KOLIŃSKI, A. 2012. Optimization of protein models. WIREs Computational Molecular Science, 2, 479-493. [40] HAN, S., SUN, J., YANG, L. & QI, M. 2020. Role of <i>NDP</i>- and <i>FZD4</i>-Related Novel Mutations Identified in Patients with FEVR in Norrin/<i>β</i>-Catenin Signaling Pathway. BioMed Research International, 2020, 7681926. 60 [41] HANANY, M. & SHARON, D. 2019. Allele frequency analysis of variants reported to cause autosomal dominant inherited retinal diseases question the involvement of 19% of genes and 10% of reported pathogenic variants. J Med Genet, 56, 536-542. [42] HENRY, C. R., SISK, R. A., TZU, J. H., ALBINI, T. A., DAVIS, J. L., MURRAY, T. G. & BERROCAL, A. M. 2015. Long-term follow-up of intravitreal bevacizumab&#xa0;for&#xa0;the treatment of pediatric retinal&#xa0;and choroidal diseases. Journal of American Association for Pediatric Ophthalmology and Strabismus {JAAPOS}, 19, 541-548. [43] HOFFMAN-ANDREWS, L. 2017. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. Journal of Law and the Biosciences, 4, 648-657. [44] HSIEH, M., BOERBOOM, D., SHIMADA, M., LO, Y., PARLOW, A. F., LUHMANN, U. F., BERGER, W. & RICHARDS, J. S. 2005. Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora lutea formation and function. Biol Reprod, 73, 1135-46. [45]JARVIK, G. P. & BROWNING, B. L. 2016. Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants. American journal of human genetics, 98, 1077-1081. [46] JIAO, X., VENTRUTO, V., TRESE, M. T., SHASTRY, B. S. & HEJTMANCIK, J. F. 2004. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. The American Journal of Human Genetics, 75, 878-884. [47] JUNG, S., BAE, S.-E., AHN, I. & SON, H. S. 2013. Protein backbone torsion angle-based structure comparison and secondary structure database web server. Genomics & informatics, 11, 155- 160. [48] JUNGE, H. J., YANG, S., BURTON, J. B., PAES, K., SHU, X., FRENCH, D. M., COSTA, M., RICE, D. S. & YE, W. 2009. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. Cell, 139, 299-311. [49] KANG, K. B., WESSEL, M. M., TONG, J., D'AMICO, D. J. & CHAN, R. V. 2013. Ultra- widefield imaging for the management of pediatric retinal diseases. J Pediatr Ophthalmol Strabismus, 50, 282-8. [50] KARCZEWSKI, K. J., FRANCIOLI, L. C., TIAO, G., CUMMINGS, B. B., ALFÖLDI, J., WANG, Q., COLLINS, R. L., LARICCHIA, K. M., GANNA, A., BIRNBAUM, D. P., GAUTHIER, L. D., BRAND, H., SOLOMONSON, M., WATTS, N. A., RHODES, D., SINGER-BERK, M., ENGLAND, E. M., SEABY, E. G., KOSMICKI, J. A., WALTERS, R. K., TASHMAN, K., FARJOUN, Y., BANKS, E., POTERBA, T., WANG, A., SEED, C., WHIFFIN, N., CHONG, J. X., SAMOCHA, K. E., PIERCE-HOFFMAN, E., ZAPPALA, Z., O’DONNELL-LURIA, A. H., MINIKEL, E. V., WEISBURD, B., LEK, M., WARE, J. S., VITTAL, C., ARMEAN, I. M., BERGELSON, L., CIBULSKIS, K., CONNOLLY, K. M., COVARRUBIAS, M., DONNELLY, S., FERRIERA, S., GABRIEL, S., GENTR Y , J., GUPT A, N., JEANDET , T ., KAPLAN, D., LLANWARNE, C., MUNSHI, R., NOVOD, S., PETRILLO, N., ROAZEN, D., RUANO-RUBIO, V., SALTZMAN, A., SCHLEICHER, M., SOTO, J., TIBBETTS, K., TOLONEN, C., WADE, G., TALKOWSKI, M. E., AGUILAR SALINAS, C. A., AHMAD, T., ALBERT, C. M., ARDISSINO, D., ATZMON, G., BARNARD, J., BEAUGERIE, L., BENJAMIN, E. J., BOEHNKE, M., BONNYCASTLE, L. L., BOTTINGER, E. P., BOWDEN, D. W., BOWN, M. J., CHAMBERS, J. C., CHAN, J. C., CHASMAN, D., CHO, J., CHUNG, M. K., COHEN, B., CORREA, A., DABELEA, D., DALY, M. J., DARBAR, D., DUGGIRALA, R., DUPUIS, J., ELLINOR, P. T., ELOSUA, R., ERDMANN, J., ESKO, T., FÄRKKILÄ, M., FLOREZ, J., FRANKE, A., GETZ, G., GLASER, B., 61 GLATT, S. J., GOLDSTEIN, D., GONZALEZ, C., GROOP, L., et al. 2020. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581, 434-443. [51] KARIMI, M., IGNASIAK, M. T., CHAN, B., CROFT, A. K., RADOM, L., SCHIESSER, C. H., PATTISON, D. I. & DAVIES, M. J. 2016. Reactivity of disulfide bonds is markedly affected by structure and environment: implications for protein modification and stability. Scientific Reports, 6, 38572. [52] KASHANI, A. H., BROWN, K. T., CHANG, E., DRENSER, K. A., CAPONE, A. & TRESE, M. T. 2014. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology, 121, 2220-2227. [53] KATAGIRI, S., YOKOI, T., YOSHIDA-UEMURA, T., NISHINA, S. & AZUMA, N. 2018. Characteristics of Retinal Breaks and Surgical Outcomes in Rhegmatogenous Retinal Detachment in Familial Exudative Vitreoretinopathy. Ophthalmology Retina, 2, 720-725. [54] KATO , M., PATEL , M. S., LEVASSEUR , R., LOBOV , I., CHANG , B. H.-J., GLASS , D. A., II, HARTMANN , C., LI , L., HWANG , T.-H., BRAYTON , C. F., LANG , R. A., KARSENTY , G. & CHAN , L. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. Journal of Cell Biology, 157, 303-314. [55] KE, J., HARIKUMAR, K. G., ERICE, C., CHEN, C., GU, X., WANG, L., PARKER, N., CHENG, Z., XU, W. & WILLIAMS, B. O. 2013. Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex. Genes & development, 27, 2305-2319. [56] KELLEY, L. A., MEZULIS, S., YATES, C. M., WASS, M. N. & STERNBERG, M. J. E. 2015. The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols, 10, 845-858. [57] KHAN, K., LOGAN, C. V., MCKIBBIN, M., SHERIDAN, E., ELCIOGLU, N. H., YENICE, O., PARRY, D. A., FERNANDEZ-FUENTES, N., ABDELHAMED, Z. I. & AL-MASKARI, A. 2011. Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defects. Human molecular genetics, 21, 776-783. [58] KLEINBERGER, J., MALONEY, K. A., POLLIN, T. I. & JENG, L. J. 2016. An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet Med, 18, 1165. [59] KONDO, H., HAYASHI, H., OSHIMA, K., TAHIRA, T. & HAYASHI, K. 2003. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. British journal of ophthalmology, 87, 1291-1295. [60] KOPANOS, C., TSIOLKAS, V., KOURIS, A., CHAPPLE, C. E., AGUILERA, M. A., MEYER, R. & MASSOURAS, A. 2019. VarSome: the human genomic variant search engine. Bioinformatics, 35, 1978. [61] KUFAREVA, I. & ABAGYAN, R. 2012. Methods of protein structure comparison. Methods Mol Biol, 857, 231-57. [62] LAI, M. B., ZHANG, C., SHI, J., JOHNSON, V ., KHANDAN, L., MCVEY , J., KLYMKOWSKY, M. W., CHEN, Z. & JUNGE, H. J. 2017. TSPAN12 is a Norrin co-receptor that amplifies Frizzled4 ligand selectivity and signaling. Cell reports, 19, 2809-2822. [63] LANDRUM, M. J., CHITIPIRALLA, S., BROWN, G. R., CHEN, C., GU, B., HART, J., HOFFMAN, D., JANG, W., KAUR, K., LIU, C., LYOSHIN, V., MADDIPATLA, Z., MAITI, R., 62 MITCHELL, J., O'LEARY, N., RILEY, G. R., SHI, W., ZHOU, G., SCHNEIDER, V., MAGLOTT, D., HOLMES, J. B. & KATTMAN, B. L. 2020. ClinVar: improvements to accessing data. Nucleic Acids Res, 48, D835-d844. [64] LANDRUM, M. J., LEE, J. M., BENSON, M., BROWN, G. R., CHAO, C., CHITIPIRALLA, S., GU, B., HART, J., HOFFMAN, D., JANG, W., KARAPETYAN, K., KATZ, K., LIU, C., MADDIPATLA, Z., MALHEIRO, A., MCDANIEL, K., OVETSKY, M., RILEY, G., ZHOU, G., HOLMES, J. B., KATTMAN, B. L. & MAGLOTT, D. R. 2018. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res, 46, D1062-d1067. [65] LAPPALAINEN, I., LOPEZ, J., SKIPPER, L., HEFFERON, T., SPALDING, J. D., GARNER, J., CHEN, C., MAGUIRE, M., CORBETT, M., ZHOU, G., PASCHALL, J., ANANIEV, V., FLICEK, P. & CHURCH, D. M. 2013. DbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Res, 41, D936-41. [66] LAQUA, H. 1980. Familial exudative vitreoretinopathy. Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 213, 121-133. [67] LASKOWSKI, R. A., RULLMANNN, J. A., MACARTHUR, M. W., KAPTEIN, R. & THORNTON, J. M. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR, 8, 477-86. [68] LI, Q. & WANG, K. 2017. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. The American Journal of Human Genetics, 100, 267-280. [69] LOVELL, S. C., DAVIS, I. W., ARENDALL, W. B., 3RD, DE BAKKER, P. I., WORD, J. M., PRISANT, M. G., RICHARDSON, J. S. & RICHARDSON, D. C. 2003. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins, 50, 437-50. [70] LU, Y.-Z., DENG, G.-D., LIU, J.-H. & YAN, H. 2018. The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater. International journal of ophthalmology, 11, 976-980. [71] LUHMANN, U. F., MEUNIER, D., SHI, W., LÜTTGES, A., PFARRER, C., FUNDELE, R. & BERGER, W. 2005. Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis, 42, 253-62. [72] LUHMANN, U. F., NEIDHARDT, J., KLOECKENER-GRUISSEM, B., SCHÄFER, N. F., GLAUS, E., FEIL, S. & BERGER, W. 2008. Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled-4. Eur J Neurosci, 27, 2619-28. [73] MICHALSKA-MAŁECKA, K., KABIESZ, A., KIMSA, M. W., STRZAŁKA-MROZIK, B., FORMIŃSKA-KAPUŚCIK, M., NITA, M. & MAZUREK, U. 2016. Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging, 11, 357-65. [74] MILLER, K. E., WILLIS, M. J. & MCCLATCHEY, S. K. 2015. A case of familial exudative vitreoretinopathy identified after genetic testing. Journal of American Association for Pediatric Ophthalmology and Strabismus, 19, 178-180. [75] MO, R., CHEW, T.-L., MAHER, M. T., BELLIPANNI, G., WEINBERG, E. S. & GOTTARDI, C. J. 2009. The terminal region of beta-catenin promotes stability by shielding the Armadillo repeats from the axin-scaffold destruction complex. The Journal of biological chemistry, 284, 28222-28231. 63 [76] MUSADA, G. R., JALALI, S., HUSSAIN, A., CHURURU, A. R., GADDAM, P. R., CHAKRABARTI, S. & KAUR, I. 2016. Mutation spectrum of the Norrie disease pseudoglioma (NDP) gene in Indian patients with FEVR. Molecular vision, 22, 491. [77] NIKOPOULOS, K., GILISSEN, C., HOISCHEN, A., VAN NOUHUYS, C. E., BOONSTRA, F. N., BLOKLAND, E. A., ARTS, P., WIESKAMP, N., STROM, T. M. & AYUSO, C. 2010. Next- generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. The American Journal of Human Genetics, 86, 240-247. [78] O’ROAK, B. J., VIVES, L., FU, W., EGERTSON, J. D., STANAWAY, I. B., PHELPS, I. G., CARVILL, G., KUMAR, A., LEE, C. & ANKENMAN, K. 2012. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science, 338, 1619-1622. [79] OSTERGAARD, P., SIMPSON, M. A., MENDOLA, A., VASUDEVAN, P., CONNELL, F. C., VAN IMPEL, A., MOORE, A. T., LOEYS, B. L., GHALAMKARPOUR, A., ONOUFRIADIS, A., MARTINEZ-CORRAL, I., DEVERY, S., LEROY, J. G., VAN LAER, L., SINGER, A., BIALER, M. G., MCENTAGART, M., QUARRELL, O., BRICE, G., TREMBATH, R. C., SCHULTE-MERKER, S., MAKINEN, T., VIKKULA, M., MORTIMER, P. S., MANSOUR, S. & JEFFERY, S. 2012. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. American journal of human genetics, 90, 356-362. [80] PANAGIOTOU, E. S., SANJURJO SORIANO, C., POULTER, J. A., LORD, E. C., DZULOVA, D., KONDO, H., HIYOSHI, A., CHUNG, B. H.-Y., CHU, Y. W.-Y., LAI, C. H. Y., TAFOYA, M. E., KARJOSUKARSO, D., COLLIN, R. W . J., TOPPING, J., DOWNEY , L. M., ALI, M., INGLEHEARN, C. F. & TOOMES, C. 2017. Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. The American Journal of Human Genetics, 100, 960-968. [81] PARK, H., OVCHINNIKOV, S., KIM, D. E., DIMAIO, F. & BAKER, D. 2018. Protein homology model refinement by large-scale energy optimization. Proceedings of the National Academy of Sciences, 115, 3054-3059. [82] PARK, H., PARK, S. Y. & RYU, S. E. 2013. Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1. Journal of Molecular Graphics and Modelling, 39, 65-70. [83] PARK, H., YAMAMOTO, H., MOHN, L., AMBÜHL, L., KANAI, K., SCHMIDT, I., KIM, K.- P., FRACCAROLI, A., FEIL, S. & JUNGE, H. J. 2019. Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nature communications, 10, 1-14. [84] PENDERGAST, S. D. & TRESE, M. T. 1998. Familial exudative vitreoretinopathy: results of surgical management. Ophthalmology, 105, 1015-1023. [85] PETTERSEN, E. F., GODDARD, T. D., HUANG, C. C., COUCH, G. S., GREENBLATT, D. M., MENG, E. C. & FERRIN, T. E. 2004. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem, 25, 1605-12. [86] POULTER, J. A., ALI, M., GILMOUR, D. F., RICE, A., KONDO, H., HAYASHI, K., MACKEY, D. A., KEARNS, L. S., RUDDLE, J. B. & CRAIG, J. E. 2010. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. The American Journal of Human Genetics, 86, 248-253. [87] POULTER, J. A., DAVIDSON, A. E., ALI, M., GILMOUR, D. F., PARRY, D. A., MINTZ- HITTNER, H. A., CARR, I. M., BOTTOMLEY, H. M., LONG, V. W. & DOWNEY, L. M. 2012. 64 Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR). Investigative ophthalmology & visual science, 53, 2873-2879. [88] PRASOV, L., MASUD, T., KHALIQ, S., MEHDI, S. Q., ABID, A., OLIVER, E. R., SILVA, E. D., LEWANDA, A., BRODSKY, M. C. & BORCHERT, M. 2012. ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary vitreous. Human molecular genetics, 21, 3681-3694. [89] QIN, M., KONDO, H., TAHIRA, T. & HAYASHI, K. 2008. Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. Human genetics, 122, 615-623. [90] QUIRAM, P. A., DRENSER, K. A., LAI, M. M., CAPONE, A. J. & TRESE, M. T. 2008. TREATMENT OF VASCULARLY ACTIVE FAMILIAL EXUDATIVE VITREORETINOPATHY WITH PEGAPTANIB SODIUM (MACUGEN). RETINA, 28. [91] RAMACHANDRAN, G. N., RAMAKRISHNAN, C. & SASISEKHARAN, V . 1963. Stereochemistry of polypeptide chain configurations. J Mol Biol, 7, 95-9. [92] REHM, H. L., ZHANG, D.-S., BROWN, M. C., BURGESS, B., HALPIN, C., BERGER, W., MORTON, C. C., COREY, D. P. & CHEN, Z.-Y. 2002. Vascular Defects and Sensorineural Deafness in a Mouse Model of Norrie Disease. The Journal of Neuroscience, 22, 4286. [93] RENTZSCH, P., WITTEN, D., COOPER, G. M., SHENDURE, J. & KIRCHER, M. 2019. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids research, 47, D886-D894. [94] RICHARDS, S., AZIZ, N., BALE, S., BICK, D., DAS, S., GASTIER-FOSTER, J., GRODY, W. W., HEGDE, M., LYON, E. & SPECTOR, E. 2015a. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine, 17, 405-423. [95] RICHARDS, S., AZIZ, N., BALE, S., BICK, D., DAS, S., GASTIER-FOSTER, J., GRODY, W. W., HEGDE, M., LYON, E., SPECTOR, E., VOELKERDING, K. & REHM, H. L. 2015b. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 17, 405-24. [96] RICHTER, M., GOTTANKA, J., MAY, C. A., WELGE-LÜSSEN, U., BERGER, W. & LÜTJEN-DRECOLL, E. 1998. Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci, 39, 2450-7. [97] ROBITAILLE, J., MACDONALD, M. L., KAYKAS, A., SHELDAHL, L. C., ZEISLER, J., DUBÉ, M.-P., ZHANG, L.-H., SINGARAJA, R. R., GUERNSEY, D. L. & ZHENG, B. 2002. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nature genetics, 32, 326. [98] ROBITAILLE, J. M., GILLETT, R. M., LEBLANC, M. A., GASTON, D., NIGHTINGALE, M., MACKLEY, M. P., PARKASH, S., HATHAWAY, J., THOMAS, A. & ELLS, A. 2014. Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations. JAMA ophthalmology, 132, 1393-1399. [99] ROBITAILLE, J. M., ZHENG, B., WALLACE, K., BEIS, M. J., TATLIDIL, C., YANG, J., SHEIDOW, T. G., SIEBERT, L., LEVIN, A. V. & LAM, W.-C. 2011. The role of Frizzled-4 mutations 65 in familial exudative vitreoretinopathy and Coats disease. British Journal of Ophthalmology, 95, 574- 579. [100] SAVISAAR, R. & HURST, L. D. 2018. Exonic splice regulation imposes strong selection at synonymous sites. Genome research, 28, 1442-1454. [101] SCHWARZ, J. M., COOPER, D. N., SCHUELKE, M. & SEELOW, D. 2014. MutationTaster2: mutation prediction for the deep-sequencing age. Nature methods, 11, 361-362. [102] SCHWEDE, T. 2013. Protein modeling: what happened to the \"protein structure gap\"? Structure (London, England : 1993), 21, 1531-1540. [103] SEEMAB, S., PERVAIZ, N., ZEHRA, R., ANWAR, S., BAO, Y. & ABBASI, A. A. 2019. Molecular evolutionary and structural analysis of familial exudative vitreoretinopathy associated FZD4 gene. BMC Evolutionary Biology, 19, 72. [104] SHUKLA, D., SINGH, J., SUDHEER, G., SOMAN, M., JOHN, R. K., RAMASAMY, K. & PERUMALSAMY, N. 2003. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. Indian J Ophthalmol, 51, 323-8. [105] SIMS, K. B. 2014. NDP-related retinopathies. GeneReviews®[Internet]. University of Washington, Seattle. [106] SIRUGO, G., WILLIAMS, S. M. & TISHKOFF, S. A. 2019. The missing diversity in human genetic studies. Cell, 177, 26-31. [107] SONI, N. & MADHUSUDHAN, M. S. 2017. Computational modeling of protein assemblies. Current Opinion in Structural Biology, 44, 179-189. [108] SONI, S. & ALOK, J. 2018. STRUCTURAL CHARACTERISATION OF 5- HYDROXYTRYPTAMINE2A RECEPTOR IN HOMO SAPIENS BY IN - SILICO METHOD. Asian Journal of Pharmaceutical and Clinical Research, 11. [109] STENSON, P. D., MORT, M., BALL, E. V., CHAPMAN, M., EVANS, K., AZEVEDO, L., HAYDEN, M., HEYWOOD, S., MILLAR, D. S., PHILLIPS, A. D. & COOPER, D. N. 2020. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting. Human Genetics, 139, 1197-1207. [110] TEMKAR, S., AZAD, S. V., CHAWLA, R., DAMODARAN, S., GARG, G., REGANI, H., NAWAZISH, S., RAJ, N. & VENKATRAMAN, V. 2019. Ultra-widefield fundus fluorescein angiography in pediatric retinal vascular diseases. Indian journal of ophthalmology, 67, 788. [111] TOOMES, C., BOTTOMLEY, H. M., JACKSON, R. M., TOWNS, K. V., SCOTT, S., MACKEY, D. A., CRAIG, J. E., JIANG, L., YANG, Z. & TREMBATH, R. 2004. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. The American Journal of Human Genetics, 74, 721-730. [112] TOOMES, C. & DOWNEY, L. 2011. Familial exudative vitreoretinopathy, autosomal dominant. GeneReviews®[Internet]. University of Washington, Seattle. [113] URANO, T., SHIRAKI, M., USUI, T., SASAKI, N., OUCHI, Y. & INOUE, S. 2009. A1330V Variant of the Low-density Lipoprotein Receptorrelated Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women. Endocrine Journal, 56, 625-631. [114] VAN DER VELDE, K. J., DE BOER, E. N., VAN DIEMEN, C. C., SIKKEMA-RADDATZ, B., ABBOTT, K. M., KNOPPERTS, A., FRANKE, L., SIJMONS, R. H., DE KONING, T. J., 66 WIJMENGA, C., SINKE, R. J. & SWER TZ, M. A. 2017. GA VIN: Gene-A ware V ariant INterpretation for medical sequencing. Genome Biology, 18, 6. [115] VAN SCHIE, E. H. & VAN AMERONGEN, R. 2020. Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence. Frontiers in cell and developmental biology, 8, 25-25. [116] VASER, R., ADUSUMALLI, S., LENG, S. N., SIKIC, M. & NG, P. C. 2016. SIFT missense predictions for genomes. Nature protocols, 11, 1. [117] WANG, Y., HUSO, D., CAHILL, H., RYUGO, D. & NATHANS, J. 2001. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. The Journal of neuroscience : the official journal of the Society for Neuroscience, 21, 4761-4771. [118] WATERHOUSE, A., BERTONI, M., BIENERT, S., STUDER, G., TAURIELLO, G., GUMIENNY, R., HEER, F. T., DE BEER, T. A P., REMPFER, C., BORDOLI, L., LEPORE, R. & SCHWEDE, T. 2018. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research, 46, W296-W303. [119] WEBB, B. & SALI, A. 2016. Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinformatics, 54, 5.6.1-5.6.37. [120] WILDEMAN, M., VAN OPHUIZEN, E., DEN DUNNEN, J. T. & TASCHNER, P. E. 2008. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat, 29, 6-13. [121] WU, J.-H., LIU, J.-H., KO, Y.-C., WANG, C.-T., CHUNG, Y.-C., CHU, K.-C., LIU, T.-T., CHAO, H.-M., JIANG, Y.-J. & CHEN, S.-J. 2016. Haploinsufficiency of RCBTB1 is associated with Coats disease and familial exudative vitreoretinopathy. Human molecular genetics, 25, 1637-1647. [122] XING, Y., TAKEMARU, K.-I., LIU, J., BERNDT, J. D., ZHENG, J. J., MOON, R. T. & XU, W. 2008. Crystal structure of a full-length β-catenin. Structure, 16, 478-487. [123] XU, Q., WANG, Y., DABDOUB, A., SMALLWOOD, P. M., WILLIAMS, J., WOODS, C., KELLEY, M. W., JIANG, L., TASMAN, W., ZHANG, K. & NATHANS, J. 2004. Vascular Development in the Retina and Inner Ear: Control by Norrin and Frizzled-4, a High-Affinity Ligand- Receptor Pair. Cell, 116, 883-895. [124] YANG, J. & ZHANG, Y. 2015. I-TASSER server: new development for protein structure and function predictions. Nucleic acids research, 43, W174-W181. [125] YANG, Z., LASKER, K., SCHNEIDMAN-DUHOVNY, D., WEBB, B., HUANG, C. C., PETTERSEN, E. F., GODDARD, T. D., MENG, E. C., SALI, A. & FERRIN, T. E. 2012. UCSF Chimera, MODELLER, and IMP: an integrated modeling system. Journal of structural biology, 179, 269-278. [126] YE, X., WANG, Y., CAHILL, H., YU, M., BADEA, T. C., SMALLWOOD, P. M., PEACHEY, N. S. & NATHANS, J. 2009. Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization. Cell, 139, 285-298. [127] YE, X., WANG, Y. & NATHANS, J. 2010. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med, 16, 417-25. [128] ZHANG, K., HARADA, Y., WEI, X., SHUKLA, D., RAJENDRAN, A., TAWANSY, K., BEDELL, M., LIM, S., SHAW, P. X. & HE, X. 2011. An essential role of the cysteine-rich domain of 67 FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy. Journal of Biological Chemistry, 286, 10210-10215. [129] ZHANG, L., ZHANG, X., XU, H., HUANG, L., ZHANG, S., LIU, W., YANG, Y., FEI, P., LI, S. & YANG, M. 2019. Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy. Genetics in Medicine, 1-8. [130] ZHAO, Y. & SINGH, R. P. 2018. The role of anti-vascular endothelial growth factor (anti- VEGF) in the management of proliferative diabetic retinopathy. Drugs in context, 7, 212532-212532."]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["masters"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["M.Sc by research"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://etheses.whiterose.ac.uk/id/eprint/28167/1/Sun_D_Medicine_MRes_2020.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal eye disease, which can lead to vision loss or total blindness. It is characterized by abnormal development of blood vessels in the retina, which may trigger neovascularization leading to retinal folds and detachment. FEVR is genetically heterogeneous with eleven genes reported to date (NDP, FZD4, LRP5, TSPAN12, CTNNB1, KIF11, ZNF408, ATOH7, RCBTB1, JAG1 and ILK) and an ever-increasing number of variants being reported in these. This project focused on generating a mutation database and spectrum for FEVR. Variant information was gathered either from unpublished data from the Toomes’ lab or from peer-reviewed journal articles. All of the mutations were annotated so that they complied with the latest Human Genome Variation Society nomenclature and were uploaded onto the Leiden Open Variation Database. Pathogenicity classifications of variants were reassessed using the latest pathogenic prediction tools and frequency data and were classified according to the American College of Medical Genetics (ACMG) guidelines. In addition, missense mutant protein structures were predicted using Modeller9.24 software and compared with the correspondent wildtype protein model using UCSF chimera to attempt to highlight differences to aid in variant classification."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Investigating the mutation spectrum for Familial Exudative Vitreoretinopathy (FEVR)"]}]}],"canonical_facts":{"dc:contributor.advisor":["Toomes, Carmel","Inglehearn, Chris","Poulter, James"],"dc:creator":["Sun, Dong"],"dc:date":["2020-09"],"dc:date.issued":["2020-09"],"dc:description.abstract":["Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal eye disease, which can lead to vision loss or total blindness. It is characterized by abnormal development of blood vessels in the retina, which may trigger neovascularization leading to retinal folds and detachment. FEVR is genetically heterogeneous with eleven genes reported to date (NDP, FZD4, LRP5, TSPAN12, CTNNB1, KIF11, ZNF408, ATOH7, RCBTB1, JAG1 and ILK) and an ever-increasing number of variants being reported in these. This project focused on generating a mutation database and spectrum for FEVR. Variant information was gathered either from unpublished data from the Toomes’ lab or from peer-reviewed journal articles. All of the mutations were annotated so that they complied with the latest Human Genome Variation Society nomenclature and were uploaded onto the Leiden Open Variation Database. Pathogenicity classifications of variants were reassessed using the latest pathogenic prediction tools and frequency data and were classified according to the American College of Medical Genetics (ACMG) guidelines. In addition, missense mutant protein structures were predicted using Modeller9.24 software and compared with the correspondent wildtype protein model using UCSF chimera to attempt to highlight differences to aid in variant classification."],"dc:format":["text"],"dc:identifier.uri":["https://etheses.whiterose.ac.uk/id/eprint/28167/1/Sun_D_Medicine_MRes_2020.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["School of Medicine (Leeds)"],"dc:publisher.institution":["University of Leeds"],"dc:relation.isreferencedby":["https://etheses.whiterose.ac.uk/id/eprint/28167/"],"dc:relation.references":["[1] Mutations and New Variation: Overview. eLS. [2] ADZHUBEI, I. A., SCHMIDT, S., PESHKIN, L., RAMENSKY, V. E., GERASIMOVA, A., BORK, P., KONDRASHOV, A. S. & SUNYAEV, S. R. 2010. A method and server for predicting damaging missense mutations. Nature methods, 7, 248-249. [3] AVILA-FERNANDEZ, A., PEREZ-CARRO, R., CORTON, M., LOPEZ-MOLINA, M. I., CAMPELLO, L., GARANTO, A., FERNANDEZ-SANCHEZ, L., DUIJKERS, L., LOPEZ- MARTINEZ, M. A. & RIVEIRO-ALVAREZ, R. 2015. Whole-exome sequencing reveals ZNF408 as a new gene associated with autosomal recessive retinitis pigmentosa with vitreal alterations. Human molecular genetics, 24, 4037-4048. [4] BANG, I., KIM, H. R., BEAVEN, A. H., KIM, J., KO, S.-B., LEE, G. R., KAN, W., LEE, H., IM, W. & SEOK, C. 2018. Biophysical and functional characterization of Norrin signaling through Frizzled4. Proceedings of the National Academy of Sciences, 115, 8787-8792. [5] BARRESI, M. J. F., BURTON, S., DIPIETRANTONIO, K., AMSTERDAM, A., HOPKINS, N. & KARLSTROM, R. O. 2010. Essential genes for astroglial development and axon pathfinding during zebrafish embryogenesis. Developmental dynamics : an official publication of the American Association of Anatomists, 239, 2603-2618. [6] BERGER, W., VAN DE POL, D., BÄCHNER, D., OERLEMANS, F., WINKENS, H., HAMEISTER, H., WIERINGA, B., HENDRIKS, W. & ROPERS, H. H. 1996. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Hum Mol Genet, 5, 51-9. [7] BRANDIS, G. & HUGHES, D. 2016. The Selective Advantage of Synonymous Codon Usage Bias in Salmonella. PLOS Genetics, 12, e1005926. [8] BROWN, N. L., PATEL, S., BRZEZINSKI, J. & GLASER, T. 2001. <em>Math5</em> is required for retinal ganglion cell and optic nerve formation. Development, 128, 2497-2508. [9] BUCHER, F., FRIEDLANDER, M. & YEA, K. 2018. Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy. Oncotarget, 9, 12538. [10] CHANG, T.-H., HSIEH, F.-L., ZEBISCH, M., HARLOS, K., ELEGHEERT, J. & JONES, E. Y. 2015. Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan. Elife, 4, e06554. [11] CHARETTE, J. R., EARP, S. E., BELL, B. A., ACKERT-BICKNELL, C. L., GODFREY, D. A., RAO, S., ANAND-APTE, B., NISHINA, P. M. & PEACHEY, N. S. 2017. A mutagenesis-derived Lrp5 mouse mutant with abnormal retinal vasculature and low bone mineral density. Molecular Vision, 23, 140. [12] CHEN, Z., BATTINELLI, E., FIELDER, A., BUNDEY, S., SIMS, K., BREAKEFIELD, X. & CRAIG, I. 1993a. A mutation in the norrie disease gene (ndp) associated with x–linked familial exudative vitreoretinopathy. Nature genetics, 5, 180. [13] CHEN, Z. Y., BATTINELLI, E. M., FIELDER, A., BUNDEY, S., SIMS, K., BREAKEFIELD, X. O. & CRAIG, I. W. 1993b. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet, 5, 180-3. [14] CHENG, J., RANDALL, A. & BALDI, P. 2006. Prediction of protein stability changes for single- site mutations using support vector machines. Proteins, 62, 1125-32. 58 [15] CHENG, J., RANDALL, A. Z., SWEREDOSKI, M. J. & BALDI, P. 2005. SCRATCH: a protein structure and structural feature prediction server. Nucleic acids research, 33, W72-W76. [16] CHOI, Y. & CHAN, A. P. 2015. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 31, 2745-2747. [17] CLEVERS, H. 2009. Eyeing up new Wnt pathway players. Cell, 139, 227-229. [18] COLLIN, R. W., NIKOPOULOS, K., DONA, M., GILISSEN, C., HOISCHEN, A., BOONSTRA, F. N., POULTER, J. A., KONDO, H., BERGER, W. & TOOMES, C. 2013. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature. Proceedings of the National Academy of Sciences, 110, 9856-9861. [19] COLLINS, J. S. & SCHWARTZ, C. E. 2002. Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet, 71, 1251-2. [20] COLOVOS, C. & YEATES, T. O. 1993. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci, 2, 1511-9. [21] COPPIETERS, F., ASCARI, G., DANNHAUSEN, K., NIKOPOULOS, K., PEELMAN, F., KARLSTETTER, M., XU, M., BRACHET, C., MEUNIER, I. & TSILIMBARIS, M. K. 2016. Isolated and syndromic retinal dystrophy caused by biallelic mutations in RCBTB1, a gene implicated in ubiquitination. The American Journal of Human Genetics, 99, 470-480. [22] CRISWICK, V. & SCHEPENS, C. 1969. Familial exudative vitreoretinopathy. American journal of ophthalmology, 68, 578-594. [23] DE LIGT, J., WILLEMSEN, M. H., VAN BON, B. W., KLEEFSTRA, T., YNTEMA, H. G., KROES, T., VULTO-VAN SILFHOUT, A. T., KOOLEN, D. A., DE VRIES, P. & GILISSEN, C. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 367, 1921-1929. [24] DEN DUNNEN, J. T., DALGLEISH, R., MAGLOTT, D. R., HART, R. K., GREENBLATT, M. S., MCGOWAN-JORDAN, J., ROUX, A.-F., SMITH, T., ANTONARAKIS, S. E. & TASCHNER, P. E. M. 2016. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Human Mutation, 37, 564-569. [25] DOWNEY , L., BOTTOMLEY , H., SHERIDAN, E., AHMED, M., GILMOUR, D., INGLEHEARN, C., REDDY, A., AGRAWAL, A., BRADBURY, J. & TOOMES, C. 2006. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. British journal of ophthalmology, 90, 1163-1167. [26] DOWNEY , L., KEEN, T., ROBERTS, E., MANSFIELD, D., BAMASHMUS, M. & INGLEHEARN, C. 2001. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. The American Journal of Human Genetics, 68, 778-781. DRENSER, K. A. 2016. Wnt signaling pathway in retinal vascularization. Eye and Brain, 8, 141. [27] DUBRUC, E., PUTOUX, A., LABALME, A., ROUGEOT, C., SANLAVILLE, D. & EDERY, P. 2014. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. American Journal of Medical Genetics Part A, 164, 1571-1575. [28] EISENBERG, D., LÜTHY, R. & BOWIE, J. U. 1997. [20] VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology. Academic Press. [29] EXERTIER, P., JAVERZAT, S., WANG, B., FRANCO, M., HERBERT, J., PLATONOVA, N., WINANDY, M., PUJOL, N., NIVELLES, O., ORMENESE, S., GODARD, V., BECKER, J., 59 BICKNELL, R., PINEAU, R., WILTING, J., BIKFALVI, A. & HAGEDORN, M. 2013. Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5. Oncotarget, 4, 2302- 2316. [30] FISCHETTO, R., PALMIERI, V. V., TRIPALDI, M. E., GAETA, A., MICHELUCCI, A., DELVECCHIO, M., FRANCAVILLA, R. & GIORDANO, P. 2019. Alagille Syndrome: A Novel Mutation in JAG1 Gene. Frontiers in pediatrics, 7, 199-199. [31] GANDHI, J. K., TOLLEFSON, T. T. & TELANDER, D. G. 2014. Falciform macular folds and chromosome 22q11.2: evidence in support of a locus for familial exudative vitreoretinopathy (FEVR). Ophthalmic Genet, 35, 112-6. [32] GHIASVAND, N. M., RUDOLPH, D. D., MASHAYEKHI, M., BRZEZINSKI IV, J. A., GOLDMAN, D. & GLASER, T. 2011. Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease. Nature neuroscience, 14, 578. [33] GILISSEN, C., HOISCHEN, A., BRUNNER, H. G. & VELTMAN, J. A. 2012. Disease gene identification strategies for exome sequencing. Eur J Hum Genet, 20, 490-7. [34] GILMOUR, D. 2015. Familial exudative vitreoretinopathy and related retinopathies. Eye, 29, 1- 14. [35] GILMOUR, D. F., DOWNEY, L. M., SHERIDAN, E., LONG, V., BRADBURY, J., INGLEHEARN, C. F. & TOOMES, C. 2009. Familial exudative vitreoretinopathy and DiGeorge syndrome: a new locus for familial exudative vitreoretinopathy on chromosome 22q11. 2? Ophthalmology, 116, 1522-1524. [36] GONG, Y., SLEE, R. B., FUKAI, N., RAWADI, G., ROMAN-ROMAN, S., REGINATO, A. M., WANG, H., CUNDY, T., GLORIEUX, F. H., LEV, D., ZACHARIN, M., OEXLE, K., MARCELINO, J., SUWAIRI, W., HEEGER, S., SABATAKOS, G., APTE, S., ADKINS, W. N., ALLGROVE, J., ARSLAN-KIRCHNER, M., BATCH, J. A., BEIGHTON, P., BLACK, G. C., BOLES, R. G., BOON, L. M., BORRONE, C., BRUNNER, H. G., CARLE, G. F., DALLAPICCOLA, B., DE PAEPE, A., FLOEGE, B., HALFHIDE, M. L., HALL, B., HENNEKAM, R. C., HIROSE, T., JANS, A., JÜPPNER, H., KIM, C. A., KEPPLER-NOREUIL, K., KOHLSCHUETTER, A., LACOMBE, D., LAMBERT, M., LEMYRE, E., LETTEBOER, T., PELTONEN, L., RAMESAR, R. S., ROMANENGO, M., SOMER, H., STEICHEN-GERSDORF, E., STEINMANN, B., SULLIVAN, B., SUPERTI-FURGA, A., SWOBODA, W., VAN DEN BOOGAARD, M. J., VAN HUL, W., VIKKULA, M., VOTRUBA, M., ZABEL, B., GARCIA, T., BARON, R., OLSEN, B. R. & WARMAN, M. L. 2001. LDL receptor- related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513-23. [37] GOTTARDI, C. J. & PEIFER, M. 2008. Terminal regions of beta-catenin come into view. Structure, 16, 336-8. [38] GOW, J. & OLIVER, G. L. 1971. Familial exudative vitreoretinopathy: an expanded view. Archives of Ophthalmology, 86, 150-155. [39] GRONT, D., KMIECIK, S., BLASZCZYK, M., EKONOMIUK, D. & KOLIŃSKI, A. 2012. Optimization of protein models. WIREs Computational Molecular Science, 2, 479-493. [40] HAN, S., SUN, J., YANG, L. & QI, M. 2020. Role of <i>NDP</i>- and <i>FZD4</i>-Related Novel Mutations Identified in Patients with FEVR in Norrin/<i>β</i>-Catenin Signaling Pathway. BioMed Research International, 2020, 7681926. 60 [41] HANANY, M. & SHARON, D. 2019. Allele frequency analysis of variants reported to cause autosomal dominant inherited retinal diseases question the involvement of 19% of genes and 10% of reported pathogenic variants. J Med Genet, 56, 536-542. [42] HENRY, C. R., SISK, R. A., TZU, J. H., ALBINI, T. A., DAVIS, J. L., MURRAY, T. G. & BERROCAL, A. M. 2015. Long-term follow-up of intravitreal bevacizumab&#xa0;for&#xa0;the treatment of pediatric retinal&#xa0;and choroidal diseases. Journal of American Association for Pediatric Ophthalmology and Strabismus {JAAPOS}, 19, 541-548. [43] HOFFMAN-ANDREWS, L. 2017. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. Journal of Law and the Biosciences, 4, 648-657. [44] HSIEH, M., BOERBOOM, D., SHIMADA, M., LO, Y., PARLOW, A. F., LUHMANN, U. F., BERGER, W. & RICHARDS, J. S. 2005. Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora lutea formation and function. Biol Reprod, 73, 1135-46. [45]JARVIK, G. P. & BROWNING, B. L. 2016. Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants. American journal of human genetics, 98, 1077-1081. [46] JIAO, X., VENTRUTO, V., TRESE, M. T., SHASTRY, B. S. & HEJTMANCIK, J. F. 2004. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. The American Journal of Human Genetics, 75, 878-884. [47] JUNG, S., BAE, S.-E., AHN, I. & SON, H. S. 2013. Protein backbone torsion angle-based structure comparison and secondary structure database web server. Genomics & informatics, 11, 155- 160. [48] JUNGE, H. J., YANG, S., BURTON, J. B., PAES, K., SHU, X., FRENCH, D. M., COSTA, M., RICE, D. S. & YE, W. 2009. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. Cell, 139, 299-311. [49] KANG, K. B., WESSEL, M. M., TONG, J., D'AMICO, D. J. & CHAN, R. V. 2013. Ultra- widefield imaging for the management of pediatric retinal diseases. J Pediatr Ophthalmol Strabismus, 50, 282-8. [50] KARCZEWSKI, K. J., FRANCIOLI, L. C., TIAO, G., CUMMINGS, B. B., ALFÖLDI, J., WANG, Q., COLLINS, R. L., LARICCHIA, K. M., GANNA, A., BIRNBAUM, D. P., GAUTHIER, L. D., BRAND, H., SOLOMONSON, M., WATTS, N. A., RHODES, D., SINGER-BERK, M., ENGLAND, E. M., SEABY, E. G., KOSMICKI, J. A., WALTERS, R. K., TASHMAN, K., FARJOUN, Y., BANKS, E., POTERBA, T., WANG, A., SEED, C., WHIFFIN, N., CHONG, J. X., SAMOCHA, K. E., PIERCE-HOFFMAN, E., ZAPPALA, Z., O’DONNELL-LURIA, A. H., MINIKEL, E. V., WEISBURD, B., LEK, M., WARE, J. S., VITTAL, C., ARMEAN, I. M., BERGELSON, L., CIBULSKIS, K., CONNOLLY, K. M., COVARRUBIAS, M., DONNELLY, S., FERRIERA, S., GABRIEL, S., GENTR Y , J., GUPT A, N., JEANDET , T ., KAPLAN, D., LLANWARNE, C., MUNSHI, R., NOVOD, S., PETRILLO, N., ROAZEN, D., RUANO-RUBIO, V., SALTZMAN, A., SCHLEICHER, M., SOTO, J., TIBBETTS, K., TOLONEN, C., WADE, G., TALKOWSKI, M. E., AGUILAR SALINAS, C. A., AHMAD, T., ALBERT, C. M., ARDISSINO, D., ATZMON, G., BARNARD, J., BEAUGERIE, L., BENJAMIN, E. J., BOEHNKE, M., BONNYCASTLE, L. L., BOTTINGER, E. P., BOWDEN, D. W., BOWN, M. J., CHAMBERS, J. C., CHAN, J. C., CHASMAN, D., CHO, J., CHUNG, M. K., COHEN, B., CORREA, A., DABELEA, D., DALY, M. J., DARBAR, D., DUGGIRALA, R., DUPUIS, J., ELLINOR, P. T., ELOSUA, R., ERDMANN, J., ESKO, T., FÄRKKILÄ, M., FLOREZ, J., FRANKE, A., GETZ, G., GLASER, B., 61 GLATT, S. J., GOLDSTEIN, D., GONZALEZ, C., GROOP, L., et al. 2020. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581, 434-443. [51] KARIMI, M., IGNASIAK, M. T., CHAN, B., CROFT, A. K., RADOM, L., SCHIESSER, C. H., PATTISON, D. I. & DAVIES, M. J. 2016. Reactivity of disulfide bonds is markedly affected by structure and environment: implications for protein modification and stability. Scientific Reports, 6, 38572. [52] KASHANI, A. H., BROWN, K. T., CHANG, E., DRENSER, K. A., CAPONE, A. & TRESE, M. T. 2014. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology, 121, 2220-2227. [53] KATAGIRI, S., YOKOI, T., YOSHIDA-UEMURA, T., NISHINA, S. & AZUMA, N. 2018. Characteristics of Retinal Breaks and Surgical Outcomes in Rhegmatogenous Retinal Detachment in Familial Exudative Vitreoretinopathy. Ophthalmology Retina, 2, 720-725. [54] KATO , M., PATEL , M. S., LEVASSEUR , R., LOBOV , I., CHANG , B. H.-J., GLASS , D. A., II, HARTMANN , C., LI , L., HWANG , T.-H., BRAYTON , C. F., LANG , R. A., KARSENTY , G. & CHAN , L. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. Journal of Cell Biology, 157, 303-314. [55] KE, J., HARIKUMAR, K. G., ERICE, C., CHEN, C., GU, X., WANG, L., PARKER, N., CHENG, Z., XU, W. & WILLIAMS, B. O. 2013. Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex. Genes & development, 27, 2305-2319. [56] KELLEY, L. A., MEZULIS, S., YATES, C. M., WASS, M. N. & STERNBERG, M. J. E. 2015. The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols, 10, 845-858. [57] KHAN, K., LOGAN, C. V., MCKIBBIN, M., SHERIDAN, E., ELCIOGLU, N. H., YENICE, O., PARRY, D. A., FERNANDEZ-FUENTES, N., ABDELHAMED, Z. I. & AL-MASKARI, A. 2011. Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defects. Human molecular genetics, 21, 776-783. [58] KLEINBERGER, J., MALONEY, K. A., POLLIN, T. I. & JENG, L. J. 2016. An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet Med, 18, 1165. [59] KONDO, H., HAYASHI, H., OSHIMA, K., TAHIRA, T. & HAYASHI, K. 2003. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. British journal of ophthalmology, 87, 1291-1295. [60] KOPANOS, C., TSIOLKAS, V., KOURIS, A., CHAPPLE, C. E., AGUILERA, M. A., MEYER, R. & MASSOURAS, A. 2019. VarSome: the human genomic variant search engine. Bioinformatics, 35, 1978. [61] KUFAREVA, I. & ABAGYAN, R. 2012. Methods of protein structure comparison. Methods Mol Biol, 857, 231-57. [62] LAI, M. B., ZHANG, C., SHI, J., JOHNSON, V ., KHANDAN, L., MCVEY , J., KLYMKOWSKY, M. W., CHEN, Z. & JUNGE, H. J. 2017. TSPAN12 is a Norrin co-receptor that amplifies Frizzled4 ligand selectivity and signaling. Cell reports, 19, 2809-2822. [63] LANDRUM, M. J., CHITIPIRALLA, S., BROWN, G. R., CHEN, C., GU, B., HART, J., HOFFMAN, D., JANG, W., KAUR, K., LIU, C., LYOSHIN, V., MADDIPATLA, Z., MAITI, R., 62 MITCHELL, J., O'LEARY, N., RILEY, G. R., SHI, W., ZHOU, G., SCHNEIDER, V., MAGLOTT, D., HOLMES, J. B. & KATTMAN, B. L. 2020. ClinVar: improvements to accessing data. Nucleic Acids Res, 48, D835-d844. [64] LANDRUM, M. J., LEE, J. M., BENSON, M., BROWN, G. R., CHAO, C., CHITIPIRALLA, S., GU, B., HART, J., HOFFMAN, D., JANG, W., KARAPETYAN, K., KATZ, K., LIU, C., MADDIPATLA, Z., MALHEIRO, A., MCDANIEL, K., OVETSKY, M., RILEY, G., ZHOU, G., HOLMES, J. B., KATTMAN, B. L. & MAGLOTT, D. R. 2018. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res, 46, D1062-d1067. [65] LAPPALAINEN, I., LOPEZ, J., SKIPPER, L., HEFFERON, T., SPALDING, J. D., GARNER, J., CHEN, C., MAGUIRE, M., CORBETT, M., ZHOU, G., PASCHALL, J., ANANIEV, V., FLICEK, P. & CHURCH, D. M. 2013. DbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Res, 41, D936-41. [66] LAQUA, H. 1980. Familial exudative vitreoretinopathy. Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 213, 121-133. [67] LASKOWSKI, R. A., RULLMANNN, J. A., MACARTHUR, M. W., KAPTEIN, R. & THORNTON, J. M. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR, 8, 477-86. [68] LI, Q. & WANG, K. 2017. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. The American Journal of Human Genetics, 100, 267-280. [69] LOVELL, S. C., DAVIS, I. W., ARENDALL, W. B., 3RD, DE BAKKER, P. I., WORD, J. M., PRISANT, M. G., RICHARDSON, J. S. & RICHARDSON, D. C. 2003. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins, 50, 437-50. [70] LU, Y.-Z., DENG, G.-D., LIU, J.-H. & YAN, H. 2018. The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater. International journal of ophthalmology, 11, 976-980. [71] LUHMANN, U. F., MEUNIER, D., SHI, W., LÜTTGES, A., PFARRER, C., FUNDELE, R. & BERGER, W. 2005. Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction. Genesis, 42, 253-62. [72] LUHMANN, U. F., NEIDHARDT, J., KLOECKENER-GRUISSEM, B., SCHÄFER, N. F., GLAUS, E., FEIL, S. & BERGER, W. 2008. Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled-4. Eur J Neurosci, 27, 2619-28. [73] MICHALSKA-MAŁECKA, K., KABIESZ, A., KIMSA, M. W., STRZAŁKA-MROZIK, B., FORMIŃSKA-KAPUŚCIK, M., NITA, M. & MAZUREK, U. 2016. Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging, 11, 357-65. [74] MILLER, K. E., WILLIS, M. J. & MCCLATCHEY, S. K. 2015. A case of familial exudative vitreoretinopathy identified after genetic testing. Journal of American Association for Pediatric Ophthalmology and Strabismus, 19, 178-180. [75] MO, R., CHEW, T.-L., MAHER, M. T., BELLIPANNI, G., WEINBERG, E. S. & GOTTARDI, C. J. 2009. The terminal region of beta-catenin promotes stability by shielding the Armadillo repeats from the axin-scaffold destruction complex. The Journal of biological chemistry, 284, 28222-28231. 63 [76] MUSADA, G. R., JALALI, S., HUSSAIN, A., CHURURU, A. R., GADDAM, P. R., CHAKRABARTI, S. & KAUR, I. 2016. Mutation spectrum of the Norrie disease pseudoglioma (NDP) gene in Indian patients with FEVR. Molecular vision, 22, 491. [77] NIKOPOULOS, K., GILISSEN, C., HOISCHEN, A., VAN NOUHUYS, C. E., BOONSTRA, F. N., BLOKLAND, E. A., ARTS, P., WIESKAMP, N., STROM, T. M. & AYUSO, C. 2010. Next- generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. The American Journal of Human Genetics, 86, 240-247. [78] O’ROAK, B. J., VIVES, L., FU, W., EGERTSON, J. D., STANAWAY, I. B., PHELPS, I. G., CARVILL, G., KUMAR, A., LEE, C. & ANKENMAN, K. 2012. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science, 338, 1619-1622. [79] OSTERGAARD, P., SIMPSON, M. A., MENDOLA, A., VASUDEVAN, P., CONNELL, F. C., VAN IMPEL, A., MOORE, A. T., LOEYS, B. L., GHALAMKARPOUR, A., ONOUFRIADIS, A., MARTINEZ-CORRAL, I., DEVERY, S., LEROY, J. G., VAN LAER, L., SINGER, A., BIALER, M. G., MCENTAGART, M., QUARRELL, O., BRICE, G., TREMBATH, R. C., SCHULTE-MERKER, S., MAKINEN, T., VIKKULA, M., MORTIMER, P. S., MANSOUR, S. & JEFFERY, S. 2012. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. American journal of human genetics, 90, 356-362. [80] PANAGIOTOU, E. S., SANJURJO SORIANO, C., POULTER, J. A., LORD, E. C., DZULOVA, D., KONDO, H., HIYOSHI, A., CHUNG, B. H.-Y., CHU, Y. W.-Y., LAI, C. H. Y., TAFOYA, M. E., KARJOSUKARSO, D., COLLIN, R. W . J., TOPPING, J., DOWNEY , L. M., ALI, M., INGLEHEARN, C. F. & TOOMES, C. 2017. Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. The American Journal of Human Genetics, 100, 960-968. [81] PARK, H., OVCHINNIKOV, S., KIM, D. E., DIMAIO, F. & BAKER, D. 2018. Protein homology model refinement by large-scale energy optimization. Proceedings of the National Academy of Sciences, 115, 3054-3059. [82] PARK, H., PARK, S. Y. & RYU, S. E. 2013. Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1. Journal of Molecular Graphics and Modelling, 39, 65-70. [83] PARK, H., YAMAMOTO, H., MOHN, L., AMBÜHL, L., KANAI, K., SCHMIDT, I., KIM, K.- P., FRACCAROLI, A., FEIL, S. & JUNGE, H. J. 2019. Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nature communications, 10, 1-14. [84] PENDERGAST, S. D. & TRESE, M. T. 1998. Familial exudative vitreoretinopathy: results of surgical management. Ophthalmology, 105, 1015-1023. [85] PETTERSEN, E. F., GODDARD, T. D., HUANG, C. C., COUCH, G. S., GREENBLATT, D. M., MENG, E. C. & FERRIN, T. E. 2004. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem, 25, 1605-12. [86] POULTER, J. A., ALI, M., GILMOUR, D. F., RICE, A., KONDO, H., HAYASHI, K., MACKEY, D. A., KEARNS, L. S., RUDDLE, J. B. & CRAIG, J. E. 2010. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. The American Journal of Human Genetics, 86, 248-253. [87] POULTER, J. A., DAVIDSON, A. E., ALI, M., GILMOUR, D. F., PARRY, D. A., MINTZ- HITTNER, H. A., CARR, I. M., BOTTOMLEY, H. M., LONG, V. W. & DOWNEY, L. M. 2012. 64 Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR). Investigative ophthalmology & visual science, 53, 2873-2879. [88] PRASOV, L., MASUD, T., KHALIQ, S., MEHDI, S. Q., ABID, A., OLIVER, E. R., SILVA, E. D., LEWANDA, A., BRODSKY, M. C. & BORCHERT, M. 2012. ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary vitreous. Human molecular genetics, 21, 3681-3694. [89] QIN, M., KONDO, H., TAHIRA, T. & HAYASHI, K. 2008. Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. Human genetics, 122, 615-623. [90] QUIRAM, P. A., DRENSER, K. A., LAI, M. M., CAPONE, A. J. & TRESE, M. T. 2008. TREATMENT OF VASCULARLY ACTIVE FAMILIAL EXUDATIVE VITREORETINOPATHY WITH PEGAPTANIB SODIUM (MACUGEN). RETINA, 28. [91] RAMACHANDRAN, G. N., RAMAKRISHNAN, C. & SASISEKHARAN, V . 1963. Stereochemistry of polypeptide chain configurations. J Mol Biol, 7, 95-9. [92] REHM, H. L., ZHANG, D.-S., BROWN, M. C., BURGESS, B., HALPIN, C., BERGER, W., MORTON, C. C., COREY, D. P. & CHEN, Z.-Y. 2002. Vascular Defects and Sensorineural Deafness in a Mouse Model of Norrie Disease. The Journal of Neuroscience, 22, 4286. [93] RENTZSCH, P., WITTEN, D., COOPER, G. M., SHENDURE, J. & KIRCHER, M. 2019. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids research, 47, D886-D894. [94] RICHARDS, S., AZIZ, N., BALE, S., BICK, D., DAS, S., GASTIER-FOSTER, J., GRODY, W. W., HEGDE, M., LYON, E. & SPECTOR, E. 2015a. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine, 17, 405-423. [95] RICHARDS, S., AZIZ, N., BALE, S., BICK, D., DAS, S., GASTIER-FOSTER, J., GRODY, W. W., HEGDE, M., LYON, E., SPECTOR, E., VOELKERDING, K. & REHM, H. L. 2015b. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 17, 405-24. [96] RICHTER, M., GOTTANKA, J., MAY, C. A., WELGE-LÜSSEN, U., BERGER, W. & LÜTJEN-DRECOLL, E. 1998. Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci, 39, 2450-7. [97] ROBITAILLE, J., MACDONALD, M. L., KAYKAS, A., SHELDAHL, L. C., ZEISLER, J., DUBÉ, M.-P., ZHANG, L.-H., SINGARAJA, R. R., GUERNSEY, D. L. & ZHENG, B. 2002. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nature genetics, 32, 326. [98] ROBITAILLE, J. M., GILLETT, R. M., LEBLANC, M. A., GASTON, D., NIGHTINGALE, M., MACKLEY, M. P., PARKASH, S., HATHAWAY, J., THOMAS, A. & ELLS, A. 2014. Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations. JAMA ophthalmology, 132, 1393-1399. [99] ROBITAILLE, J. M., ZHENG, B., WALLACE, K., BEIS, M. J., TATLIDIL, C., YANG, J., SHEIDOW, T. G., SIEBERT, L., LEVIN, A. V. & LAM, W.-C. 2011. The role of Frizzled-4 mutations 65 in familial exudative vitreoretinopathy and Coats disease. British Journal of Ophthalmology, 95, 574- 579. [100] SAVISAAR, R. & HURST, L. D. 2018. Exonic splice regulation imposes strong selection at synonymous sites. Genome research, 28, 1442-1454. [101] SCHWARZ, J. M., COOPER, D. N., SCHUELKE, M. & SEELOW, D. 2014. MutationTaster2: mutation prediction for the deep-sequencing age. Nature methods, 11, 361-362. [102] SCHWEDE, T. 2013. Protein modeling: what happened to the \"protein structure gap\"? Structure (London, England : 1993), 21, 1531-1540. [103] SEEMAB, S., PERVAIZ, N., ZEHRA, R., ANWAR, S., BAO, Y. & ABBASI, A. A. 2019. Molecular evolutionary and structural analysis of familial exudative vitreoretinopathy associated FZD4 gene. BMC Evolutionary Biology, 19, 72. [104] SHUKLA, D., SINGH, J., SUDHEER, G., SOMAN, M., JOHN, R. K., RAMASAMY, K. & PERUMALSAMY, N. 2003. Familial exudative vitreoretinopathy (FEVR). Clinical profile and management. Indian J Ophthalmol, 51, 323-8. [105] SIMS, K. B. 2014. NDP-related retinopathies. GeneReviews®[Internet]. University of Washington, Seattle. [106] SIRUGO, G., WILLIAMS, S. M. & TISHKOFF, S. A. 2019. The missing diversity in human genetic studies. Cell, 177, 26-31. [107] SONI, N. & MADHUSUDHAN, M. S. 2017. Computational modeling of protein assemblies. Current Opinion in Structural Biology, 44, 179-189. [108] SONI, S. & ALOK, J. 2018. STRUCTURAL CHARACTERISATION OF 5- HYDROXYTRYPTAMINE2A RECEPTOR IN HOMO SAPIENS BY IN - SILICO METHOD. Asian Journal of Pharmaceutical and Clinical Research, 11. [109] STENSON, P. D., MORT, M., BALL, E. V., CHAPMAN, M., EVANS, K., AZEVEDO, L., HAYDEN, M., HEYWOOD, S., MILLAR, D. S., PHILLIPS, A. D. & COOPER, D. N. 2020. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting. Human Genetics, 139, 1197-1207. [110] TEMKAR, S., AZAD, S. V., CHAWLA, R., DAMODARAN, S., GARG, G., REGANI, H., NAWAZISH, S., RAJ, N. & VENKATRAMAN, V. 2019. Ultra-widefield fundus fluorescein angiography in pediatric retinal vascular diseases. Indian journal of ophthalmology, 67, 788. [111] TOOMES, C., BOTTOMLEY, H. M., JACKSON, R. M., TOWNS, K. V., SCOTT, S., MACKEY, D. A., CRAIG, J. E., JIANG, L., YANG, Z. & TREMBATH, R. 2004. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. The American Journal of Human Genetics, 74, 721-730. [112] TOOMES, C. & DOWNEY, L. 2011. Familial exudative vitreoretinopathy, autosomal dominant. GeneReviews®[Internet]. University of Washington, Seattle. [113] URANO, T., SHIRAKI, M., USUI, T., SASAKI, N., OUCHI, Y. & INOUE, S. 2009. A1330V Variant of the Low-density Lipoprotein Receptorrelated Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women. Endocrine Journal, 56, 625-631. [114] VAN DER VELDE, K. J., DE BOER, E. N., VAN DIEMEN, C. C., SIKKEMA-RADDATZ, B., ABBOTT, K. M., KNOPPERTS, A., FRANKE, L., SIJMONS, R. H., DE KONING, T. J., 66 WIJMENGA, C., SINKE, R. J. & SWER TZ, M. A. 2017. GA VIN: Gene-A ware V ariant INterpretation for medical sequencing. Genome Biology, 18, 6. [115] VAN SCHIE, E. H. & VAN AMERONGEN, R. 2020. Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence. Frontiers in cell and developmental biology, 8, 25-25. [116] VASER, R., ADUSUMALLI, S., LENG, S. N., SIKIC, M. & NG, P. C. 2016. SIFT missense predictions for genomes. Nature protocols, 11, 1. [117] WANG, Y., HUSO, D., CAHILL, H., RYUGO, D. & NATHANS, J. 2001. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. The Journal of neuroscience : the official journal of the Society for Neuroscience, 21, 4761-4771. [118] WATERHOUSE, A., BERTONI, M., BIENERT, S., STUDER, G., TAURIELLO, G., GUMIENNY, R., HEER, F. T., DE BEER, T. A P., REMPFER, C., BORDOLI, L., LEPORE, R. & SCHWEDE, T. 2018. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research, 46, W296-W303. [119] WEBB, B. & SALI, A. 2016. Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinformatics, 54, 5.6.1-5.6.37. [120] WILDEMAN, M., VAN OPHUIZEN, E., DEN DUNNEN, J. T. & TASCHNER, P. E. 2008. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat, 29, 6-13. [121] WU, J.-H., LIU, J.-H., KO, Y.-C., WANG, C.-T., CHUNG, Y.-C., CHU, K.-C., LIU, T.-T., CHAO, H.-M., JIANG, Y.-J. & CHEN, S.-J. 2016. Haploinsufficiency of RCBTB1 is associated with Coats disease and familial exudative vitreoretinopathy. Human molecular genetics, 25, 1637-1647. [122] XING, Y., TAKEMARU, K.-I., LIU, J., BERNDT, J. D., ZHENG, J. J., MOON, R. T. & XU, W. 2008. Crystal structure of a full-length β-catenin. Structure, 16, 478-487. [123] XU, Q., WANG, Y., DABDOUB, A., SMALLWOOD, P. M., WILLIAMS, J., WOODS, C., KELLEY, M. W., JIANG, L., TASMAN, W., ZHANG, K. & NATHANS, J. 2004. Vascular Development in the Retina and Inner Ear: Control by Norrin and Frizzled-4, a High-Affinity Ligand- Receptor Pair. Cell, 116, 883-895. [124] YANG, J. & ZHANG, Y. 2015. I-TASSER server: new development for protein structure and function predictions. Nucleic acids research, 43, W174-W181. [125] YANG, Z., LASKER, K., SCHNEIDMAN-DUHOVNY, D., WEBB, B., HUANG, C. C., PETTERSEN, E. F., GODDARD, T. D., MENG, E. C., SALI, A. & FERRIN, T. E. 2012. UCSF Chimera, MODELLER, and IMP: an integrated modeling system. Journal of structural biology, 179, 269-278. [126] YE, X., WANG, Y., CAHILL, H., YU, M., BADEA, T. C., SMALLWOOD, P. M., PEACHEY, N. S. & NATHANS, J. 2009. Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization. Cell, 139, 285-298. [127] YE, X., WANG, Y. & NATHANS, J. 2010. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med, 16, 417-25. [128] ZHANG, K., HARADA, Y., WEI, X., SHUKLA, D., RAJENDRAN, A., TAWANSY, K., BEDELL, M., LIM, S., SHAW, P. X. & HE, X. 2011. An essential role of the cysteine-rich domain of 67 FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy. Journal of Biological Chemistry, 286, 10210-10215. [129] ZHANG, L., ZHANG, X., XU, H., HUANG, L., ZHANG, S., LIU, W., YANG, Y., FEI, P., LI, S. & YANG, M. 2019. Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy. Genetics in Medicine, 1-8. [130] ZHAO, Y. & SINGH, R. P. 2018. The role of anti-vascular endothelial growth factor (anti- VEGF) in the management of proliferative diabetic retinopathy. Drugs in context, 7, 212532-212532."],"dcterms:accessrights":["public"],"dc:title":["Investigating the mutation spectrum for Familial Exudative Vitreoretinopathy (FEVR)"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["masters"],"dc:type.qualificationname":["M.Sc by research"],"person:identifier.orcid":["0000000203490821"]},"updated_at":"2026-11-18T22:40:49Z"}